ES
30
Projects
12
Coordinated
7
As Partner
€849,988
Total Budget
Budget Range
Min
€1,500
Average
€28,333
Max
€135,169
Role Distribution
Sector Distribution
Budget by Sector (€)
Projects (30)
P
Understanding Lung Cancer related risk factors and their Impact
HORIZON.2.1101096473
€135,169
C
Data-driven cancer genome interpretation for personalised cancer treatment
Health101057509
€95,843
P
Discovering the causes of three poorly understood cancers in Europe
Health101096888
€88,578
P
A European-wide foundation to accelerate Data-driven Cancer Research
Research Infrastructures101058427
€78,145
P
Causative Link between respirAtory syncytial viRus and chronic lung diseases: Identifying Targets for therapY
Health101137201
€70,546
P
European Training Network on Integrating AI in Proteomics: From Data Acquisition to Translational Applications
HORIZON.1.2101227009
€46,359
C
Deconstructing adaptive evolution of metastasis
MSCA (Marie Skłodowska-Curie)101169223
€35,166
P
BioExcel Centre of Excellence for Computational Biomolecular Research
HORIZON.2.4101093290
€29,369
C
Molecular Dynamics Data Bank. The European Repository for Biosimulation Data
Research Infrastructures101094651
€26,496
P
Carreras Postdoc Program Empowering Future Leaders to Fight Blood Cancers
HORIZON.1.2101081347
€22,925
P
Mutational processes and impact of structural variants in somatic cells
ERC (European Research Council)101088342
€19,994
C
Unmasking Non-Genetic Determinants Instructing Tumor Initiation (IGNITE)
HORIZON.1.1101171929
€19,950
P
Enabling the next generation in search of blood cancer cures
HORIZON.1.2101126688
€18,816
P
VHIO International postDoctoral programme for translAtional research
MSCA (Marie Skłodowska-Curie)101179122
€17,194
C
IRB Barcelona International PhD Programme: Driving talent towards professional excellence and high impact biomedicine.
MSCA (Marie Skłodowska-Curie)101217394
€15,840
P
IDIBAPS Doctoral programme Yielding Novel Advancements in Medicine and Innovative Solutions
MSCA (Marie Skłodowska-Curie)101217395
€15,840
C
Origins and Consequences of Hematopoietic Stem Cell Memories
HORIZON.1.1101042992
€15,000
P
Oncogenic competence during development – When, Where and Why?
HORIZON.1.1101076506
€14,999
C
Chemical rewiring of E3 ubiquitin ligases as a generalizable therapeutic approach
ERC (European Research Council)101040046
€14,996
C
Studying the metabolism and function of myeloid dendritic cells and neutrophils in distinct tissues in health and aging
ERC (European Research Council)101117470
€14,995
C
Circadian system ageing in cancer: from tumourigenesis to treatment
HORIZON.1.1101220661
€14,993
P
BUILDING INTEGRATIVE SINGLE CELL OMICS CAPACITIES USING INVERTEBRATE TUMOR MODELS RELEVANT TO HUMAN DISEASE
Widening Participation101159925
€14,069
C
IRB Barcelona International PhD programme: on TARGET for high-impact biomedicine
MSCA (Marie Skłodowska-Curie)101126676
€13,440
C
Detection and elimination of senescent cells targeting Cyclophilin D
MSCA (Marie Skłodowska-Curie)101060172
€1,653
C
Targeted Protein Degradation as a Therapeutic Strategy for the Treatment of Gastrointestinal Stromal Tumour (GIST)
MSCA (Marie Skłodowska-Curie)101154879
€1,653
C
Connecting mitochondrial defects to reduced autophagy in metabolic liver diseases through FATP2.
MSCA (Marie Skłodowska-Curie)101105864
€1,653
C
Understanding the Maintenance and Heritability of Hematopoietic Stem Cell Memories: High-Throughput Drug Screening Meets Single-Cell Barcoding
MSCA (Marie Skłodowska-Curie)101109276
€1,653
C
PROSTarget: Understanding the aggressive nature and key molecular drivers of metastatic dissemination in lethal PCa.
MSCA (Marie Skłodowska-Curie)101108377
€1,653
C
Targeting Palmitic Acid Signaling Machinery to Inhibit Metastatic Cancer
HORIZON.1.1101138836
€1,500
P
Computational multiplexing to optimise next-generation sequencing
HORIZON.1.1101123165
€1,500